Trial intelligence / Profile preview

Timing of influenza vaccination after rituximab-containing chemotherapy in non-Hodgkin lymphoma

NL-OMON38294Not yet recruiting

Sponsor
St. Antonius Ziekenhuis
Start
Sep 2012
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Open-label trial of influenza vaccine in influenza (3 arms), sponsored by St. Antonius Ziekenhuis. Primary endpoint: Percentage responders. Planned start Sep 2012; status: not yet recruiting.

02

Drugs

influenza vaccine
03

Conditions

influenza

Beyond the preview

Go deeper on NL-OMON38294.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON38294.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call